(DHR)

Role: SVP - Corporate Development
Signature: James F. O'Reilly, attorney-in-fact for Daniel Raskas
Stock symbol: DHR
Transactions as of: Nov 26, 2021
Transactions value $: -$3,434,123
Form type: 4
Date filed: 11/30/2021, 04:01 PM
Previous filing: Sep 1, 2021
Next filing: Dec 1, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DHR	Common Stock	Options Exercise	$567K	+12.3K	+54.55%	$46.13	34.9K	Nov 26, 2021	Direct
transaction	DHR	Common Stock	Sale	-$4M	-12.3K	-35.29%	$325.33	22.6K	Nov 26, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DHR	Danaher Stock Option Plan	Options Exercise	$0	-12.3K	-50.01%	$0.00	12.3K	Nov 26, 2021	Common Stock	12.3K	$46.13	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.16 to $325.525, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F2	One-third of the options granted vested on each of the third, fourth and fifth anniversaries of the grant date.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.16 to $325.525, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

One-third of the options granted vested on each of the third, fourth and fifth anniversaries of the grant date.